Pay in 4 interest-free payments of $5.99 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
PMID: 40789979 Seiwerth S, et al
For their research, published in The Lancet, the team designed a randomised controlled phase 3 trial to definitively determine whether exenatide use was associated with any benefit in people with Parkinsons disease and if it led to a slower rate of progression of the illness, after smaller studies had suggested the drug may be helpful
An important societal question is access equity
Thus, TZP was introduced for the first time, to enhance the effectiveness of incretins and reduce side effects
4AllFamily.com
doi: 10.1016/S2213-8587(19)30180-9 47 MuskietM
US$ 20.02
US$ 29.78
US$ 23.84
US$ 26.98
